William Hunt

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor”.

Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

Annals of the American Thoracic Society(2025)10.1513/annalsats.202507-817oc

N/A

0.396DataRank · unranked

8 citations

T. Spencer Poore, Brandie D. Wagner, Jing Xie, Sonya L. Heltshe, Mary Cross +65 more

242 An open-label trial to evaluate elexacaftor-tezacaftor-ivacaftor and induced pluripotent stem cell–derived model systems in individuals with residual CFTR activity

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01171-2

N/A

0DataRank · unranked

0 citations

George M. Solomon, Shingo Suzuki, András Rab, C. Barillà, Arlene A. Stecenko +11 more